2003
DOI: 10.1590/s1516-31802003000300006
|View full text |Cite
|
Sign up to set email alerts
|

Abstract: CONTEXT: Patients with refractory juvenile idiopathic arthritis can benefit from aggressive therapy. CASE REPORT: We followed the clinical course of 4 patients (2 male, 2 female) aged 9.1-17.8 years (mean of 14.5 years) with polyarticular onset of juvenile rheumatoid arthritis and one 16-year-old boy with juvenile spondyloarthropathy associated with inflammatory bowel disease. All the juvenile rheumatoid arthritis patients fulfilled the diagnostic criteria established by the American College of Rheumatology. A… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2008
2008
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(1 citation statement)
references
References 8 publications
0
1
0
Order By: Relevance
“…The most important factors limiting the applicability of CP are adverse effects. As described in previous studies, the most common early adverse effects were nausea, vomiting and various infections [15,16]. All the patients who experienced nausea or vomiting were treated with standard doses of ondansetron in oral or intravenous form, which resulted in relief of the symptoms [17].…”
Section: Discussionmentioning
confidence: 99%
“…The most important factors limiting the applicability of CP are adverse effects. As described in previous studies, the most common early adverse effects were nausea, vomiting and various infections [15,16]. All the patients who experienced nausea or vomiting were treated with standard doses of ondansetron in oral or intravenous form, which resulted in relief of the symptoms [17].…”
Section: Discussionmentioning
confidence: 99%